ArticleOncology letters2019

Epidermal growth factor receptor mutation subtype has differential effects on adjuvant chemotherapy for resected adenocarcinoma pathological stages II-III.

Yohei Kawaguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.